ALT — the liver enzyme that often signals fatty liver first
Paired condition: Metabolic syndrome lab panel
Quick answer
ALT (alanine aminotransferase) is an enzyme concentrated in liver cells; it leaks into the blood when those cells are stressed or damaged. The most common reason for a mildly elevated ALT in an otherwise well person is metabolic (fatty) liver disease — now called MASLD — which tracks closely with insulin resistance. A subtlety many people miss: the "normal" upper limit many labs print is higher than the healthy thresholds derived from truly healthy donors.
Reference ranges and interpretation
| Value / population | Classification | What it means |
|---|---|---|
| ≈ 7 – 33 U/L (women), 7 – 40 (men) | Common lab range | Typical printed reference range; varies by lab. |
| ≤ 19 U/L (women), ≤ 30 (men) | Healthy-donor threshold | Stricter limits derived from studies of truly healthy people. |
| Mild elevation (~1–3× upper limit) | Usually metabolic | Most often fatty liver (MASLD); confirm and contextualize. |
| Marked elevation (> 5–10×) | Prompt evaluation | Suggests significant hepatocellular injury; see a clinician. |
"Within range" isn't the same as "optimal" for ALT. Studies of healthy donors support lower limits (~19 U/L women, ~30 U/L men) than many labs use, so a high-normal ALT can still be worth acting on.
What a mildly elevated ALT usually means
ALT vs AST — and why the ratio matters
- AST > ALT (ratio > 2) — more suggestive of alcohol-related liver injury or advanced fibrosis
- Very high both — acute hepatocellular injury (viral, toxic, ischemic)
What to check alongside ALT
- Fasting insulin / HbA1c / triglycerides — the metabolic drivers behind MASLD
- Waist circumference, blood pressure — the rest of the metabolic-syndrome picture
- A fibrosis estimate (e.g., FIB-4) — flags who needs specialist assessment
Phi Longevity reads every marker on every lab you upload — together, against your history, against optimal ranges, and across time. The integrated picture tells you what a single number can't.
Start with my labs →Frequently asked questions
My ALT is "in range" but near the top — does that matter?
It can. Studies of truly healthy donors support lower healthy limits (~19 U/L in women, ~30 U/L in men) than many labs print. A high-normal ALT alongside insulin resistance or high triglycerides can be an early metabolic (fatty liver) signal worth addressing, even if it isn't formally "flagged."
Can exercise raise my ALT?
Vigorous exercise, especially resistance training, can transiently raise ALT and AST because these enzymes also come from muscle. If a mild elevation follows a hard workout, retesting after a few days of rest often clarifies whether the liver is really involved.
What lowers a metabolic ALT elevation?
Because most mild elevations reflect fatty liver tied to insulin resistance, the measures that improve it are metabolic: weight loss (even 5–10% helps), reducing refined carbohydrates and alcohol, and increasing activity. ALT often falls as the underlying metabolic picture improves. Any persistent elevation should be evaluated by a clinician.
Is a normal ALT a clean bill of liver health?
Not entirely. ALT can be normal even when meaningful liver disease (including fibrosis) is present, which is why clinicians look at the full pattern and, when indicated, fibrosis scores or imaging rather than relying on ALT alone.
References
All citations verified against PubMed / publisher of record (see note below for this page's verification date).
- 1.Kwo PY, Cohen SM, Lim JK. (2017). ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries. American Journal of Gastroenterology. 112(1):18-35. — Framework for interpreting ALT/AST/ALP/bilirubin as a pattern; healthy ALT thresholds and workup.PubMed →DOI →
- 2.Prati D, Taioli E, Zanella A, et al. (2002). Updated definitions of healthy ranges for serum alanine aminotransferase levels. Annals of Internal Medicine. 137(1):1-10. — Source for the stricter healthy ALT limits (~19 U/L women, ~30 U/L men) derived from healthy donors.PubMed →DOI →
- 3.Rinella ME, Lazarus JV, Ratziu V, et al. (2023). A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 78(6):1966-1986. — The 2023 renaming of NAFLD to MASLD, emphasizing the metabolic basis behind most mild ALT elevations.PubMed →DOI →
Reference ranges vary by lab and assay. "Optimal" limits reflect healthy-donor studies and a proactive reading; they are stricter than many standard lab flags. This page is educational and not a substitute for individualized medical advice.
By Steve Pinedo
Co-founder, Phi Longevity
Last updated: 2026-07-20
Steve Pinedo is the Co-founder of Phi Longevity, the AI application that turns a confusing stack of lab reports, wearable data, and clinical notes into a single, integrated picture of your health. He started Phi Longevity to make proactive health and wellness far easier to achieve. He realized how difficult it was for clients to manage their own care, records and coordination so he assembled a comprehensive M.D. led clinical team behind the platform, packaging the proactive-care experience that delivered measurable outcomes (lower triglycerides, reduced body fat, improved LDL, balanced hormones, relief from long-running autoimmune conditions) for any patient with a complicated lab to use now with an application. More about Phi Longevity →